Transcriptional Control of Myocardin and the MYOCARDome

心肌素和 MYOCARDome 的转录控制

基本信息

  • 批准号:
    10059023
  • 负责人:
  • 金额:
    $ 36.13万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-11-21 至 2022-06-30
  • 项目状态:
    已结题

项目摘要

Vascular smooth muscle cells (VSMCs) support nascent blood vessels during early development, but then acquire an advanced differentiated phenotype essential for contraction and blood flow regulation. The major effector of VSMC differentiation is the Serum Response Factor-Myocardin (SRF/MYOCD) transcriptional switch, which binds CArG boxes found in many VSMC-restricted genes. This switch is often compromised in disease states leading to VSMC de-differentiation. While levels of Myocardin are known to be reduced in disease, we know virtually nothing about its regulatory control in vivo. Moreover, the downstream targets of MYOCD (most notably, long noncoding RNAs) are not entirely known. We have generated a number of new mouse models and enabling genomic data that allow us to rapidly define the transcriptional control of Myocd in vivo and elucidate the function of novel SRF-dependent and SRF-independent MYOCD targets. We propose three aims that leverage mouse models with the revolutionary CRISPR-Cas9 genome editing system and state-of-the-art tools in genetics and genomics to test the hypothesis that SRF-dependent and SRF-independent transcription of Myocd and the downstream MYOCARDome function to maintain VSMC homeostasis. Aim 1 will utilize a new, biallelic-tagged Myocd mouse to interrogate candidate enhancers and regulatory elements defined through ChIP-seq, computational prediction, luciferase assay, or circular chromosome conformation capture (4C) assays. Two and three component CRISPR will inform those regulatory regions of critical importance for Myocardin expression. Aim 2 will utilize CRISPR-mediated loss-of-function mice and RNA-seq to begin deciphering the function of two novel genes discovered in screens for MYOCD-inducibility: an SRF-dependent long noncoding RNA gene (Mymsl) and an SRF-independent protein-coding gene (Kank1). Both genes are enriched in VSMC and appear to function in the maintenance of normal VSMC differentiation. ChIP-seq studies will ascertain and validate these MYOCD targets while disclosing the full MYOCARDome in VSMC using the dual epitope- tagged mice of Aim 1. Aim 3 will further characterize the critical regulatory elements (Aim 1) and novel MYOCD target genes (Aim 2) in models of vascular pathobiology (arterial-venous fistula and aortic aneurysm). In addition, we will make use of new loss- and gain-of-function Myocd mice to further advance our understanding of this critical cofactor and its downstream program in relevant models of human disease where the VSMC differentiation program is compromised. Completion of the aims will vertically advance our understanding of the regulatory processes undergirding Myocd expression and the function of novel MYOCD target genes under normal and disease conditions. Such knowledge will inform the next generation of experimental and clinical studies designed to maintain normal levels of Myocardin as a means of thwarting the pervasive de-differentiation of VSMC observed in human disease.
血管平滑肌细胞(VSMC)在早期发育过程中支持新生血管,但随后 获得对收缩和血流调节至关重要的高级分化表型。主要 VSMC分化的效应因子是血清反应因子-心肌细胞素(SRF/MYOCD)转录 开关,其结合在许多VSMC限制性基因中发现的CArG盒。这个开关经常被破坏 导致VSMC去分化的疾病状态。虽然已知心肌素的水平会降低, 疾病,我们几乎不知道它在体内的调节控制。此外,下游目标 MYOCD(最值得注意的是,长非编码RNA)并不完全已知。我们已经产生了一些新的 小鼠模型和使基因组数据,使我们能够快速确定Myocd的转录控制 并阐明新的SRF依赖性和SRF非依赖性MYOCD靶点的功能。我们 提出三个目标,利用具有革命性CRISPR-Cas9基因组编辑的小鼠模型 系统和国家的最先进的工具,在遗传学和基因组学,以测试的假设, Myocd和下游MYOCARDome的SRF非依赖性转录, 维持VSMC稳态。Aim 1将利用一种新的双等位基因标记的Myocd小鼠来询问 通过ChIP-seq定义的候选增强子和调控元件,计算预测, 荧光素酶测定或环状染色体构象捕获(4C)测定。二组分和三组分 CRISPR将告知那些对Myocardin表达至关重要的调控区域。目标2将 利用CRISPR介导的功能丧失小鼠和RNA-seq,开始破译两种新的 MYOCD诱导基因筛选中发现的基因:一种SRF依赖性长非编码RNA基因 (Mymsl)和SRF非依赖性蛋白质编码基因(Kankl)。这两种基因在VSMC中富集, 似乎在维持正常VSMC分化中起作用。ChIP-seq研究将确定和 验证这些MYOCD靶点,同时使用双表位公开VSMC中的完整MYOCARDome- Aim 1的标记小鼠。目的3将进一步表征关键调控元件(目的1)和新的 血管病理学模型(动静脉瘘和主动脉瘤)中MYOCD靶基因(Aim 2) 动脉瘤)。此外,我们将利用新的功能丧失和功能获得的Myocd小鼠进一步推进 我们对这一关键辅因子及其在人类疾病相关模型中的下游程序的理解 VSMC的差异化计划受到影响。目标的完成将纵向推进我们的 了解Myocd表达的调控过程和新的Myocd基因的功能, 正常和疾病条件下的MYOCD靶基因。这样的知识将告知下一代 旨在维持正常水平的Myocardin作为一种手段, 阻止在人类疾病中观察到的VSMC的普遍去分化。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Joseph M Miano其他文献

Joseph M Miano的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Joseph M Miano', 18)}}的其他基金

Regulation and Function of SRF in Vascular Pathiobiology
SRF 在血管病理生物学中的调节和功能
  • 批准号:
    10337251
  • 财政年份:
    2019
  • 资助金额:
    $ 36.13万
  • 项目类别:
Role of Smooth Muscle Calponin in Vascular Pathobiology
平滑肌钙调蛋白在血管病理学中的作用
  • 批准号:
    10053587
  • 财政年份:
    2019
  • 资助金额:
    $ 36.13万
  • 项目类别:
Transcriptional Control of Myocardin and the MYOCARDome
心肌素和 MYOCARDome 的转录控制
  • 批准号:
    10210425
  • 财政年份:
    2019
  • 资助金额:
    $ 36.13万
  • 项目类别:
Role of Smooth Muscle Calponin in Vascular Pathobiology
平滑肌钙调蛋白在血管病理学中的作用
  • 批准号:
    10077575
  • 财政年份:
    2019
  • 资助金额:
    $ 36.13万
  • 项目类别:
Regulation and Function of SRF in Vascular Pathiobiology
SRF 在血管病理生物学中的调节和功能
  • 批准号:
    9764180
  • 财政年份:
    2019
  • 资助金额:
    $ 36.13万
  • 项目类别:
Role of Smooth Muscle Calponin in Vascular Pathobiology
平滑肌钙调蛋白在血管病理学中的作用
  • 批准号:
    10308708
  • 财政年份:
    2019
  • 资助金额:
    $ 36.13万
  • 项目类别:
Regulation and Function of SRF in Vascular Pathiobiology
SRF 在血管病理生物学中的调节和功能
  • 批准号:
    10112303
  • 财政年份:
    2019
  • 资助金额:
    $ 36.13万
  • 项目类别:
Regulation and Function of SRF in Vascular Pathiobiology
SRF 在血管病理生物学中的调节和功能
  • 批准号:
    10060485
  • 财政年份:
    2019
  • 资助金额:
    $ 36.13万
  • 项目类别:
Regulation and Function of Myocardin in Vascular Pathobiology
心肌素在血管病理学中的调控和功能
  • 批准号:
    9042030
  • 财政年份:
    2013
  • 资助金额:
    $ 36.13万
  • 项目类别:
Regulation and Function of Myocardin in Vascular Pathobiology
心肌素在血管病理学中的调控和功能
  • 批准号:
    8820129
  • 财政年份:
    2013
  • 资助金额:
    $ 36.13万
  • 项目类别:

相似国自然基金

Cortical control of internal state in the insular cortex-claustrum region
  • 批准号:
  • 批准年份:
    2020
  • 资助金额:
    25 万元
  • 项目类别:

相似海外基金

CAREER: Elucidating Biogenic Control of Heterogenous Ice Nucleation
职业:阐明异质冰核的生物控制
  • 批准号:
    2336558
  • 财政年份:
    2024
  • 资助金额:
    $ 36.13万
  • 项目类别:
    Continuing Grant
CAREER: Resilient and Efficient Automatic Control in Energy Infrastructure: An Expert-Guided Policy Optimization Framework
职业:能源基础设施中的弹性和高效自动控制:专家指导的政策优化框架
  • 批准号:
    2338559
  • 财政年份:
    2024
  • 资助金额:
    $ 36.13万
  • 项目类别:
    Standard Grant
CAREER: Data-Enabled Neural Multi-Step Predictive Control (DeMuSPc): a Learning-Based Predictive and Adaptive Control Approach for Complex Nonlinear Systems
职业:数据支持的神经多步预测控制(DeMuSPc):一种用于复杂非线性系统的基于学习的预测和自适应控制方法
  • 批准号:
    2338749
  • 财政年份:
    2024
  • 资助金额:
    $ 36.13万
  • 项目类别:
    Standard Grant
Molecular Control of Thermomechanics and Shape-Morphing of Dynamic Covalent Polymer Networks
热机械的分子控制和动态共价聚合物网络的形状变形
  • 批准号:
    2406256
  • 财政年份:
    2024
  • 资助金额:
    $ 36.13万
  • 项目类别:
    Standard Grant
CAREER: Facilitating Autonomy of Robots Through Learning-Based Control
职业:通过基于学习的控制促进机器人的自主性
  • 批准号:
    2422698
  • 财政年份:
    2024
  • 资助金额:
    $ 36.13万
  • 项目类别:
    Continuing Grant
PZT-hydrogel integrated active non-Hermitian complementary acoustic metamaterials with real time modulations through feedback control circuits
PZT-水凝胶集成有源非厄米互补声学超材料,通过反馈控制电路进行实时调制
  • 批准号:
    2423820
  • 财政年份:
    2024
  • 资助金额:
    $ 36.13万
  • 项目类别:
    Standard Grant
Collaborative Research: How do plants control sperm nuclear migration for successful fertilization?
合作研究:植物如何控制精子核迁移以成功受精?
  • 批准号:
    2334517
  • 财政年份:
    2024
  • 资助金额:
    $ 36.13万
  • 项目类别:
    Standard Grant
Collaborative Research: NSF-BSF: How cell adhesion molecules control neuronal circuit wiring: Binding affinities, binding availability and sub-cellular localization
合作研究:NSF-BSF:细胞粘附分子如何控制神经元电路布线:结合亲和力、结合可用性和亚细胞定位
  • 批准号:
    2321481
  • 财政年份:
    2024
  • 资助金额:
    $ 36.13万
  • 项目类别:
    Continuing Grant
Collaborative Research: NSF-BSF: How cell adhesion molecules control neuronal circuit wiring: Binding affinities, binding availability and sub-cellular localization
合作研究:NSF-BSF:细胞粘附分子如何控制神经元电路布线:结合亲和力、结合可用性和亚细胞定位
  • 批准号:
    2321480
  • 财政年份:
    2024
  • 资助金额:
    $ 36.13万
  • 项目类别:
    Continuing Grant
CAREER: A Universal Framework for Safety-Aware Data-Driven Control and Estimation
职业:安全意识数据驱动控制和估计的通用框架
  • 批准号:
    2340089
  • 财政年份:
    2024
  • 资助金额:
    $ 36.13万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了